Skip to main content

Lantheus Holdings Inc

For the period ended Dec 31, 2023. Filed Feb 22, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 22, 2024

LNTH$101.01+0.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 2. Properties

The following table summarizes information regarding our significant leased and owned properties, as of December 31, 2023:

LocationPurposeSquare FootageOwnershipLease TermEnd
U.S.
North Billerica, MassachusettsManufacturing, Laboratory, Mixed Use and Other Office Space431,000OwnedN/A
Bedford, MassachusettsExecutive Offices, Laboratory, Office Space88,200LeasedDecember 2039
New York, New YorkOffice Space26,000Leased*September 2030
Somerset, New JerseyManufacturing, Mixed Use and Office Space11,400LeasedNovember 2028
Somerset, New JerseyOffice Space8,249LeasedMarch 2027
Canada
QuebecMixed Use and Office Space1,106LeasedMay 2024
QuebecDistribution Center and Office Space1,433LeasedMay 2025
Sweden
LundOffice Space4,000LeasedDecember 2024
  • On October 11, 2021, we entered into an agreement to sublease our office space at the World Trade Center in New York City to an unrelated third party. Please refer to Note 16, “Leases” for further details.

** On January 9, 2024, we announced that Perspective agreed to acquire the assets and associated lease of our radiopharmaceutical manufacturing facility in Somerset, New Jersey, subject to customary closing conditions, including regulatory approval.

We believe all of these facilities are well-maintained and suitable for the office, manufacturing or warehouse operations conducted in them and provide adequate capacity for current and foreseeable future needs.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.